Observational Study of Pertuzumab Safety in Participants With Breast Cancer
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: Breast Cancer
Interventions: DRUG: Pertuzumab
Sponsor: Hoffmann-La Roche